MMED Financials

Income Statement
MetricQ1 2027Q4 2026
Revenue
843.0M
+0.7%
837.0M
Cost of Revenue
378.0M
+5.9%
357.0M
Gross Profit
465.0M
-3.1%
480.0M
Operating Expenses
461.0M
-19.5%
573.0M
R&D
115.0M
+16.2%
99.0M
SG&A
312.0M
+4.3%
299.0M
Operating Income
4.0M
+104.3%
-93000000
EBITDA
43.0M
+150.0%
-86000000
Net Income
0
+100.0%
-185000000
EPS (Basic)
$0.00
—
EPS (Diluted)
$0.00
—
Shares (Diluted)
281.0M
—
MiniMed (MMED) — Financials